Rx/Reimbursement Adult Incontinence in Argentina

May 2026
USD 1,195
Request More Information

Delivery:

Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).

This report comes in PDF with additional info in Excel included.

Overview:

Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Argentina with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.

Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.

If you're in the Rx/Reimbursement adult incontinence industry in Argentina, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.

The Rx/Reimbursement adult incontinence in Argentina report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volume and value sizes, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent research methodology, conducted in-country

This report answers:

  • What is the market size of Rx/Reimbursement adult incontinence in Argentina?
  • Which are the leading brands in Rx/Reimbursement adult incontinence in Argentina?
  • How are products distributed in Rx/Reimbursement adult incontinence in Argentina?
  • How is the rise of e-commerce changing the retail and competitive landscape?
  • How has COVID-19 impacted demand? Where have sales increased due to stockpiling amidst national lockdown?
  • How have enforced home seclusion and social distancing measures following COVID-19 changed usage patterns for Rx/Reimbursement adult incontinence products?
  • Where is future growth expected to be most dynamic?
  • How important will sustainability and recycling be in generating future growth?

Rx/Reimbursement Adult Incontinence in Argentina - Category analysis

Key Data Insights

Government Supply Ensures Essential Access Despite Budget Cuts
Chart 1 Key Industry Trends for Rx/Reimbursement Adult Incontinence
Government Supply Ensures Essential Access Despite Budget Cuts
Public Sector Maintains Basic Product Offering as Population Ages
Pensioners’ Complaints Prompt Scrutiny of Basic Product Quality
Chart 2 Value Sales 2020-2030
Chart 3 Volume Sales 2020-2030
Pami Prioritises Basic Access as Elderly Population Set to Increase
Chart 4 Forecast Value Sales 2020-2030
Liberty and Nochissimo Secure Lead as Rivals Exit Distribution
Pami Transitions to Home Delivery, Replacing Pharmacy Pick-Up
Chart 5 Economic Context for Rx/Reimbursement Adult Incontinence
Chart 6 Real Gdp Growth 2020-2030
Chart 7 Inflation 2020-2030
Chart 8 Consumer Context for Rx/Reimbursement Adult Incontinence
Chart 9 Population 2020-2030
Chart 10 Consumer Expenditure 2020-2030
Chart 11 Population by Generation 2025

Tissue and Hygiene in Argentina - Industry Overview

Premiumisation Remains a Key Trend as Consumers Prioritise Comfort

Key Data Insights

Chart 12 Key Industry Trends for Tissue and Hygiene
Premiumisation Remains a Key Trend as Consumers Prioritise Comfort
Clean Wellness and Segmentation Drive Category Growth
Chart 13 Huggies Launches Premium Diapers For Sensitive Skin
Chart 14 Value Sales 2020-2030
Chart 15 Value Sales by Category 2025
Declining Birth Rates Are Expected to Have Negative Effect on Nappies/Diapers/Pants
Chart 16 Analyst Insight for Tissue and Hygiene
Hypermarkets Expected to Win Back Consumers with Promotions and Engaging Shopping Experiences
Chart 17 Forecast Value Sales 2020-2030
Chart 18 Forecast Value Sales by Category 2025-2030
Softys and Kimberly-Clark Strengthen Lead as Innovation Offsets Private Label Losses
Chart 19 Company Shares 2025
Chart 20 Brand Shares 2025
Hypermarkets Expand Reach as Price Controls End and Shoppers Seek Variety
E-Commerce Gains Momentum as Older Shoppers Adapt and Platforms Improve
Chart 21 Retail Channels 2020-2025
Chart 22 Economic Context for Tissue and Hygiene
Chart 23 Real Gdp Growth 2020-2030
Chart 24 Inflation 2020-2030
Chart 25 Consumer Context for Tissue and Hygiene
Chart 26 Population 2020-2030
Chart 27 Consumer Expenditure 2020-2030
Chart 28 Population by Generation 2025

Country Reports Disclaimer

Rx/Reimbursement adult incontinence

To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.

See all of our definitions
Share:

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.

NEW REPORT GUARANTEE

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!